Aural Analytics
Aural Analytics develops Speech Vitals, a clinical-grade speech analytics platform that extracts objective neuro-biomarkers from speech for neurological disease monitoring, serving pharmaceutical clinical trials, healthcare systems, and sports medicine applications in up to 30 languages.
- Company typePrivate
- Founded2015
- HeadquartersScottsdale, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Aural Analytics does
Aural Analytics is a clinical-grade speech analytics company spun out of Arizona State University in 2015 and headquartered in Scottsdale, Arizona. The company develops Speech Vitals, a cloud-based platform that combines speech signal processing with cognitive-linguistic analysis to extract objective neuro-biomarkers from speech samples collected via mobile devices. The technology analyzes multiple dimensions of speech production — including respiratory support, phonation quality, articulation rate, oral-nasal resonance, and language complexity — to produce clinically interpretable metrics validated across 15 disease conditions spanning ALS, Parkinson's, Alzheimer's, concussion, autism, depression, and migraine. The Speech Vitals–ALS module received FDA Breakthrough Device Designation in March 2023, and the broader platform was registered with the FDA as a Class II Software as a Medical Device (Computerized Cognitive Assessment Aid) in October 2022.
The product portfolio consists of the Speech Vitals Collection App (iOS/Android), the Speech Vitals-ALS module, and the A2E SDK, which enables embedding of speech endpoints into third-party iOS, Android, and web applications in up to 30 languages. Aural Analytics serves three primary customer segments: pharmaceutical and life sciences companies using Speech Vitals as a digital biomarker endpoint in clinical trials; healthcare systems and neurology practices for cognitive assessment and disease monitoring; and sports medicine organizations for sideline concussion assessment (notably via the HitCheck integration). Distribution is primarily B2B enterprise SaaS subscriptions and SDK licensing, with quote-based multi-year contracts to pharma sponsors, CROs, healthcare systems, and digital biomarker platforms including Medidata's Sensor Cloud Network and Koneksa.
The company is ISO 9001:2015 and ISO 13485:2016 certified, HIPAA and GDPR compliant, and has executed notable engagements including the HEALEY ALS Platform trial with Prilenia Therapeutics (where speech biomarkers first suggested therapeutic efficacy), a Phase III cognitive impairment program with Boehringer Ingelheim, and ALS early-detection work with EverythingALS. In March 2024, Aural Analytics was acquired by Linus Health Inc., a digital cognitive assessment platform, to integrate advanced speech analytics into Linus's broader brain-health offering.
Aural Analytics firmographics
Firmographics- Name
- Aural Analytics
- Legal name
- Aural Analytics, Inc.
- Website
- https://auralanalytics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- Aural Analytics develops Speech Vitals, a clinical-grade speech analytics platform that extracts objective neuro-biomarkers from speech for neurological disease monitoring, serving pharmaceutical clinical trials, healthcare systems, and sports medicine applications in up to 30 languages.
- Ownership category
- akta.pro rank
Aural Analytics industry classification
Industry- Product category
- Clinical Speech Analytics Software
- NAICS
- Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210), Information (51)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Speech Recognition, Dictation & Medical Transcription Platforms (HLACAAAI)
- akta.pro secondary industries
- Audio & Speech Analytics (call analytics, QA, insights) (HDAAAFAH), On-Device Speech & Audio AI (wake word, ASR, enhancement) (HDAAAJAF)
Keywords
Where Aural Analytics is headquartered
LocationHeadquarters
- HQ city
- Scottsdale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Aural Analytics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Speech Vitals SaaS Platform: Cloud-based subscription licensing of the Speech Vitals platform for clinical trials, remote patient monitoring, and healthcare system deployment. The platform is SDK-ready and embeddable into provider applications for seamless clinical integration.
- A2E SDK Licensing: License fees for embedding the A2E (Aural Analytics Embed) Software Development Kit into third-party clinical research, pharmaceutical, telemedicine, and academic platforms. Supports standard, hybrid and decentralized pharmaceutical clinical trials, remote monitoring and telemedicine deployments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise SaaS licensing for pharmaceutical companies, healthcare systems, and research institutions |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Aural Analytics product offering
Product offeringCore offering
Aural Analytics builds Speech Vitals, a cloud-based clinical-grade speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into APIs to extract neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples. The platform exposes these capabilities via the Speech Vitals mobile app and the A2E SDK for embedding into third-party iOS, Android, and web applications, serving pharmaceutical clinical trials, neurology practices, and concussion assessment use cases.
Product overview
Aural Analytics offers Speech Vitals, a unified cloud-based clinical-grade speech analytics platform. The product portfolio consists of Speech Vitals (core platform) for extracting validated speech biomarkers, Speech Vitals - ALS (specialized variant with FDA Breakthrough Device Designation for ALS monitoring), and the A2E SDK for embedding speech analytics into third-party applications. The Speech Vitals Collection App serves as the patient-facing mobile interface. Together these products enable remote, frequent speech assessments for neurological and respiratory health monitoring across clinical trials and healthcare settings, available in up to 30 languages.
Differentiator
Problem solved
Functional benefit
Brands
- Speech Vitals: Clinical-grade speech analytics platform that collects speech samples via app-based tasks measuring speaking rate, articulatory precision, phonatory duration and other metrics. FDA-registered as a Computerized Cognitive Assessment Aid.
- A2E (Aural Analytics Embed)
- Speech Vitals - ALS
Products and services
- Speech Vitals Cloud-based clinical-grade speech analytics platform combining speech signal processing and cognitive-linguistic analysis into APIs to extract clinically interpretable neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples collected via mobile app-based tasks, for use in clinical trials, neurology practices, and remote patient monitoring.
- Speech Vitals - ALS ALS-specific speech analytics software collecting speaking rate, articulatory precision, phonatory duration, and other speech-motor metrics via app-based tasks to assist neurologists in monitoring ALS progression in adults in clinic and at home.
- A2E (Aural Analytics Embed) SDK Software Development Kit that lets clinical researchers, pharmaceutical sponsors, telemedicine providers, and CROs embed Speech Vitals speech analytics endpoints into iOS, Android, and web applications with minimal code, supporting standard, hybrid, and decentralized clinical trials and remote monitoring.
- Speech Vitals Collection App Mobile application for collecting speech samples from patients via structured elicitation tasks, capturing speaking rate, articulatory precision, word search time, and other validated metrics; available on iOS and Android and SDK-ready for embedding into provider and healthcare system applications.
Quantifiable outcome
- Slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision) in ALS patients taking Pridopidine vs. placebo, as demonstrated in the HEALEY ALS Platform trial Regimen D
- +2 more outcomes
Companies that use Aural Analytics
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Aural Analytics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature5 records
Aural Analytics partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- Linus HealthcoreLinus Health acquired Aural Analytics in March 2024 to strengthen its digital cognitive assessment platform with advanced speech analytics for early detection of cognitive impairments. Linus Health presented clinical validation studies at AD/PD conferences and has partnerships with pharmaceutical and life sciences companies supporting clinical trials for Alzheimer's, Parkinson's, ALS, and mental health conditions.
- Prilenia TherapeuticscoreAural Analytics' Speech Vitals platform was used in the HEALEY ALS Platform trial (Regimen D) evaluating Pridopidine, where the speech-motor module demonstrated that participants taking Pridopidine showed slowing of decline in speech production attributes (sustained phonation, speaking rate, articulation rate, articulatory precision). This was the first time a speech-based digital biomarker suggested therapeutic efficacy in a large-scale pre-registered interventional trial.
- HitCheckcoreAural Analytics embedded its clinical-grade speech analytics into HitCheck's cognitive assessment app to enhance sideline concussion protocol decision-making. The partnership adds a sub-2-minute speech assessment to HitCheck's interactive, game-like concussion screening, comparing post-injury results against athletes' personal baseline assessments. HitCheck serves 200,000+ users across four countries with partnerships including the NFL Alumni Association and Baylor Scott & White Health.
- EverythingALScoreAural Analytics was selected for EverythingALS' 12-month early detection study for ALS using Speech Vitals technology. The study aims to demonstrate efficacy of speech analysis in early ALS detection using data from speech analytics, sole-based sensors, and hand-held spirometer integrated with demographics and clinical data, with the goal of developing a novel Digital ALSFRS-R scale.
- MedidatacoreAural Analytics' Speech Vitals integrated as a standard offering within Medidata's Sensor Cloud Network, enabling pharmaceutical researchers to leverage speech analytics at scale across clinical trials. This collaboration deploys Speech Vitals to further the breadth of data streams for researchers to characterize treatment effect, phenotype participants, and gain real-world disease understanding.
- KoneksacorePartnership to integrate speech collection into Koneksa's clinical trials and digital biomarker development programs with a focus on neurodegenerative conditions. The goal is to make it easy to add speech measures to Koneksa studies across pharma development and commercial pipelines, with both companies' research-grade platforms optimized for clinical trials at scale.
- Southwest Autism Research & Resource Center (SARRC)coreAural Analytics, SARRC, and Arizona State University partnered on an interventional clinical research study targeting cognition, social communication and mood in adults with autism spectrum disorder. Aural Analytics sponsors speech and language biomarker collection via its Speech Vitals platform, integrated into a behavioral intervention study (Strengthening Skills program combining PEERS and cognitive compensation training) for 48 autistic adults aged 21-70 over two years.
- Arizona State UniversitycorePartnership with ASU's College of Health Solutions alongside SARRC on autism spectrum disorder research. ASU and SARRC had previously conducted research showing reduced executive functioning and elevated depression/anxiety in middle-age autistic adults. Aural Analytics' speech biomarkers will measure cognitive and social communication outcomes in the study.
- MedableminorPartnership in the NIH Cancer Moonshot Project, integrating speech analytics into Medable's decentralized clinical research platform to support the initiative's goals of improving patient access and engagement in cancer research.
- Boehringer IngelheimcorePartnership with Boehringer Ingelheim on an innovative Phase III program for a breakthrough therapy in cognitive impairment associated with schizophrenia, using Aural Analytics' Speech Vitals speech analytics platform.
- Bio-HermesminorAural Analytics participated in the Bio-Hermes Clinical Trial, which launched to compare biomarker tests and seek rapid, less expensive diagnostics for Alzheimer's Disease, contributing speech analytics as a digital biomarker modality.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Aural Analytics competitors and assessment
Company assessmentBroad incumbents
- Linus Health: Parent company of Aural Analytics and a digital cognitive assessment platform targeting early detection of cognitive impairment. Operates in the same neurological assessment category with overlapping pharma and clinical research customers, and acquired Aural Analytics in March 2024 to incorporate speech-based digital biomarkers.
- Medidata (Dassault Systèmes): Clinical trial technology platform with Sensor Cloud Network integrating Aural Analytics' Speech Vitals. A large incumbent offering speech analytics as a standard offering within its broader clinical research suite.
- Bioclinica (Clario): Clinical trial technology and imaging provider offering decentralized trial solutions and digital biomarkers, including for CNS indications. Competes with Aural Analytics as a broad incumbent in trial endpoint technology.
Direct peers
- Winterlight Labs: Speech analytics company developing vocal biomarkers for cognitive impairment and CNS clinical trials. Closely comparable to Aural Analytics in applying speech-based digital endpoints to neurodegenerative and psychiatric drug development.
- Sonde Health: Vocal biomarker company using short voice samples to detect and monitor health conditions including mental and cognitive health. Targets similar enterprise customers (health plans, pharma, digital health) with speech-based health monitoring.
- Modality.ai: AI-driven speech and video assessment platform for neurological and psychiatric conditions. Provides remote, automated clinical assessments using speech and facial analysis, directly competing in digital biomarker space for clinical trials and tele-neurology.
- Koneksa: Digital biomarker company integrating wearables and remote assessments into clinical trials for pharma and academic research. Partner of Aural Analytics (Speech Vitals integrated into Koneksa platform) and a peer in digital biomarker deployment for CNS trials.
- Cambridge Cognition: Provider of cognitive assessment tools and digital biomarkers for CNS clinical trials, including speech-based and computerized tests. Serves pharma, biotech, and academic researchers with validated cognitive endpoints, comparable to Speech Vitals.
- Cogstate: Computerized cognitive assessment provider for clinical trials, healthcare, and concussion management. A peer in digital cognitive testing with FDA-cleared tools, overlapping in CNS clinical trial endpoints and concussion screening markets.
Emerging players
- HitCheck: Cognitive assessment mobile application for concussion screening used by sports organizations. Partner that embeds Aural Analytics' speech analytics for its sub-2-minute speech assessment component.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Aural Analytics social profiles
Digital presenceAural Analytics compliance and trust
Trust signalCompliance5 records
Aural Analytics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aural Analytics leadership team
Management profileNumber of profiles
Profiles3 records
Aural Analytics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aural Analytics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aural Analytics
What does Aural Analytics do?
Aural Analytics builds Speech Vitals, a cloud-based clinical-grade speech analytics platform that combines speech signal processing and cognitive-linguistic analysis into APIs to extract neuro-biomarker measures (respiratory support, phonation quality, articulation rate, oral-nasal resonance, language complexity) from speech samples. The platform exposes these capabilities via the Speech Vitals mobile app and the A2E SDK for embedding into third-party iOS, Android, and web applications, serving pharmaceutical clinical trials, neurology practices, and concussion assessment use cases.
Is Aural Analytics a public or private company?
Aural Analytics is a private company. It is classified as corporate owned and is currently acquired.
When was Aural Analytics founded?
Aural Analytics was founded in 2015. It employs 11 to 50 people.
Where is Aural Analytics based?
Aural Analytics is headquartered in Scottsdale, United States, in the North America region.
How does Aural Analytics make money?
Two revenue lines are on record. Speech Vitals SaaS Platform is the primary driver. The others are A2E SDK Licensing.
Who are Aural Analytics's main competitors?
Broad incumbents on record are Linus Health, Medidata (Dassault Systèmes) and Bioclinica (Clario). Direct peers are Winterlight Labs, Sonde Health, Modality.ai, Koneksa, Cambridge Cognition and Cogstate. HitCheck is listed as an emerging player.
Does Aural Analytics have an API?
Yes. A2E (Aural Analytics Embed) is a Software Development Kit (SDK) that enables clinical researchers and partners to embed speech endpoints into any application (iOS, Android, and web), available in 14+ languages, compliant with HIPAA and GDPR. The SDK provides speech elicitation and analytics that can be integrated with only a few lines of code, targeting pharmaceutical clinical trials, remote monitoring, and telemedicine use cases. The platform supports structured speech tasks and returns validated metrics including speaking rate, articulatory precision, phonatory duration, and other disease-relevant measures.
What industry is Aural Analytics in?
Aural Analytics's product category is Clinical Speech Analytics Software. Its primary akta.pro industry code is HLACAAAI, Speech Recognition, Dictation & Medical Transcription Platforms, with a secondary code of HDAAAFAH, Audio & Speech Analytics (call analytics, QA, insights). Its NAICS code is 518210 and its SIC code is 8000.